Psychostimulant augmentation of second generation antidepressants: a case series.
The authors attempted to treat Major Depressive Disorder (MDD) suboptimally responsive to one of the newer (second-generation) antidepressants by augmentation with a psychostimulant medication. Seven cases of MDD showing a partial response to an adequate trial of a second generation antidepressant were augmented with a psychostimulant. A marked improvement in clinical symptoms of depression was noted in all cases, with particular improvement in apathy and feelings of fatigue. Psychostimulant augmentation of the newer generation antidepressants is a promising new strategy. Further controlled investigation is warranted to explore various aspect of this method.